Inhibition of RNA-binding proteins enhances immunotherapy in ovarian cancer
{{output}}
High-grade serous ovarian cancer (HGSC) accounts for more than 70% of ovarian cancer-related deaths, yet therapeutic progress remains stagnant. Among the four molecular subtypes reported for HGSC, the C5 subtype is distinguished by high proliferation and immun... ...
